Grants and Contributions:
Title:
ARP - Feasibility - Development of In-Vitro Cancer Models
Agreement Number:
970229
Agreement Value:
$50,000.00
Agreement Date:
Apr 26, 2021 - Oct 31, 2021
Description:
Developing a minimum viable product (MVP) of a 3D cellular model of cancer that will help cancer drug developers be more efficient by using physiologically relevant disease models.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Quebec, Quebec, CA G1W 2G7
Reference Number:
172-2021-2022-Q1-970229
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
718552334
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by -203 days.
Amendment Date
Sep 20, 2021
Recipient's Legal Name:
Saguaro Technologies inc.
Federal Riding Name:
Louis-Hébert
Federal Riding Number:
24044
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: